405 related articles for article (PubMed ID: 25514463)
1. The Na⁺/H⁺ exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells.
Amith SR; Wilkinson JM; Baksh S; Fliegel L
Oncotarget; 2015 Jan; 6(2):1262-75. PubMed ID: 25514463
[TBL] [Abstract][Full Text] [Related]
2. KR-33028, a potent inhibitor of the Na
Amith SR; Wilkinson JM; Fliegel L
Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
[TBL] [Abstract][Full Text] [Related]
3. Expression and modulation of Na(+) /H(+) exchanger 1 gene in hepatocellular carcinoma: A potential therapeutic target.
Yang X; Wang D; Dong W; Song Z; Dou K
J Gastroenterol Hepatol; 2011 Feb; 26(2):364-70. PubMed ID: 21261728
[TBL] [Abstract][Full Text] [Related]
4. Na+/H+ exchanger NHE1 regulation modulates metastatic potential and epithelial-mesenchymal transition of triple-negative breast cancer cells.
Amith SR; Wilkinson JM; Fliegel L
Oncotarget; 2016 Apr; 7(16):21091-113. PubMed ID: 27049728
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells.
Reshkin SJ; Bellizzi A; Cardone RA; Tommasino M; Casavola V; Paradiso A
Clin Cancer Res; 2003 Jun; 9(6):2366-73. PubMed ID: 12796407
[TBL] [Abstract][Full Text] [Related]
7. NBCn1 and NHE1 expression and activity in DeltaNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pHi regulation and chemotherapy resistance.
Lauritzen G; Jensen MB; Boedtkjer E; Dybboe R; Aalkjaer C; Nylandsted J; Pedersen SF
Exp Cell Res; 2010 Sep; 316(15):2538-53. PubMed ID: 20542029
[TBL] [Abstract][Full Text] [Related]
8. MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer.
Oudin MJ; Barbier L; Schäfer C; Kosciuk T; Miller MA; Han S; Jonas O; Lauffenburger DA; Gertler FB
Mol Cancer Ther; 2017 Jan; 16(1):143-155. PubMed ID: 27811011
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix composition and interstitial pH modulate NHE1-mediated melanoma cell motility.
Vahle AK; Domikowsky B; Schwöppe C; Krähling H; Mally S; Schäfers M; Hermann S; Shahin V; Haier J; Schwab A; Stock C
Int J Oncol; 2014 Jan; 44(1):78-90. PubMed ID: 24173371
[TBL] [Abstract][Full Text] [Related]
10. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
Blanchard Z; Paul BT; Craft B; ElShamy WM
Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
[TBL] [Abstract][Full Text] [Related]
11. Defining the Na
Amith SR; Vincent KM; Wilkinson JM; Postovit LM; Fliegel L
Cell Signal; 2017 Jan; 29():69-77. PubMed ID: 27751915
[TBL] [Abstract][Full Text] [Related]
12. The Na+/H+ exchanger NHE1, but not the Na+, HCO3(-) cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2.
Lauritzen G; Stock CM; Lemaire J; Lund SF; Jensen MF; Damsgaard B; Petersen KS; Wiwel M; Rønnov-Jessen L; Schwab A; Pedersen SF
Cancer Lett; 2012 Apr; 317(2):172-83. PubMed ID: 22120673
[TBL] [Abstract][Full Text] [Related]
13. Permissive role of Na
Li X; Fliegel L
Mol Cell Biochem; 2022 Apr; 477(4):1207-1216. PubMed ID: 35084672
[TBL] [Abstract][Full Text] [Related]
14. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Na+/H+ Exchanger (NHE1) in Breast Cancer Metastasis.
Amith SR; Fliegel L
Cancer Res; 2013 Feb; 73(4):1259-64. PubMed ID: 23393197
[TBL] [Abstract][Full Text] [Related]
16. NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP.
Lin Y; Chang G; Wang J; Jin W; Wang L; Li H; Ma L; Li Q; Pang T
Exp Cell Res; 2011 Aug; 317(14):2031-40. PubMed ID: 21669197
[TBL] [Abstract][Full Text] [Related]
17. Organellar (Na+, K+)/H+ exchanger NHE7 regulates cell adhesion, invasion and anchorage-independent growth of breast cancer MDA-MB-231 cells.
Onishi I; Lin PJ; Numata Y; Austin P; Cipollone J; Roberge M; Roskelley CD; Numata M
Oncol Rep; 2012 Feb; 27(2):311-7. PubMed ID: 22076128
[TBL] [Abstract][Full Text] [Related]
18. A novel NHE1-centered signaling cassette drives epidermal growth factor receptor-dependent pancreatic tumor metastasis and is a target for combination therapy.
Cardone RA; Greco MR; Zeeberg K; Zaccagnino A; Saccomano M; Bellizzi A; Bruns P; Menga M; Pilarsky C; Schwab A; Alves F; Kalthoff H; Casavola V; Reshkin SJ
Neoplasia; 2015 Feb; 17(2):155-66. PubMed ID: 25748234
[TBL] [Abstract][Full Text] [Related]
19. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
20. [Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway.
Muscella A; Vetrugno C; Calabriso N; Cossa LG; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2014; 9(11):e112186. PubMed ID: 25372487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
